P2RY8 inhibitors are a class of chemical compounds that specifically target and inhibit the P2RY8 protein, a member of the purinergic receptor family. P2RY8 is a G-protein-coupled receptor (GPCR) that is involved in responding to extracellular nucleotides, such as ATP and UTP, which are critical signaling molecules in a variety of cellular processes. These receptors are known to mediate various functions related to cellular communication, including the regulation of immune responses, cell migration, and intracellular signaling pathways. By inhibiting P2RY8, these compounds block the receptor's ability to respond to nucleotide signals, disrupting the downstream G-protein-mediated signaling cascades that play essential roles in cellular regulation and homeostasis.
P2RY8 inhibitors are important research tools used to study the molecular mechanisms underlying purinergic signaling. Blocking P2RY8 activity allows researchers to investigate how the inhibition of nucleotide signaling affects processes such as cell communication, chemotaxis, and cellular responses to environmental changes. Additionally, these inhibitors provide insights into how P2RY8 interacts with other purinergic receptors and G-proteins in complex signaling networks. By examining the effects of P2RY8 inhibition, scientists can better understand its specific contributions to maintaining cellular function and how purinergic signaling pathways integrate with other regulatory systems. This research aids in mapping out the broader role of nucleotide receptors like P2RY8 in various biological processes, offering deeper insights into cell signaling dynamics and receptor function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine-5′-Diphosphate, free acid | 58-64-0 | sc-291846 sc-291846A sc-291846B sc-291846C sc-291846D sc-291846E | 100 mg 500 mg 1 g 10 g 100 g 500 g | $77.00 $180.00 $312.00 $924.00 $4596.00 $9186.00 | 1 | |
ADP is involved in purinergic signaling and can modulate GPCR activity, potentially influencing P2RY8. | ||||||
Uridine-5′-triphosphate, Trisodium Salt | 19817-92-6 | sc-301964 sc-301964A | 50 mg 1 g | $86.00 $118.00 | 2 | |
UTP, a purinergic signaling molecule, may influence P2RY8 or its related pathways in the purinergic signaling system. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $456.00 | ||
GTPγS is used to activate G-proteins in GPCR pathways, potentially influencing P2RY8 signaling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can modulate GPCR signaling, potentially impacting P2RY8. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $199.00 $460.00 $1479.00 | 1 | |
NF449 is a potent P2X1 receptor antagonist, which might indirectly influence P2RY8 through modulating purinergic signaling. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $145.00 $450.00 | 11 | |
PPADS is a selective antagonist of P2X receptors and can be used to study the indirect effects on P2RY8. | ||||||